Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates

Published on January 26, 2022

Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.

Continue reading on website
Other news

Gary Vaynerchuk to Open World's First NFT Restaurant in NYC

January 26, 2022
The members-only Flyfish Club will require members to pay for their access with crypto.

Fed News to Prompt Stock Markets Today

January 26, 2022
This would be an excellent time for Fed Chair Powell to address investors' worry.